-

Accresa Secures Second U.S. Patent, Asserts Leadership and Ownership of DPC Technology

The only known patented technology platform in direct primary care reinforces its intellectual property rights in healthcare affiliate management and payment technology.

CARROLLTON, Texas--(BUSINESS WIRE)--Accresa Health, a pioneer in direct primary care (DPC) technology, today announced the issuance of its second U.S. patent (No. 12,770,120 B2), further establishing its position as the only known DPC technology platform holding issued U.S. patents.

The new patent strengthens Accresa's intellectual property portfolio covering innovations in affiliate management, healthcare network administration, and payment technology. Together with its first U.S. patent (No. 12,682,329 B2), it protects inventions developed by Accresa to manage complex relationships and financial transactions among employers, healthcare providers, medical groups, and patients.

"Accresa developed this technology through years of investment, innovation, and hard work. The issuance of our second U.S. patent further affirms our ownership of the intellectual property underlying these innovations," said William C. Short, CEO of Accresa. "Others have attempted to replicate to compete, but innovation and imitation are not the same thing. We intend to aggressively protect our intellectual property and pursue every appropriate avenue to enforce our patent rights, including against companies currently commercializing technology that infringes our patents. We will not stand by while others profit from innovations we worked to create."

Accresa remains committed to advancing the growth and accessibility of direct primary care, a model the company believes is essential to building a better healthcare system in America. By continuing to invest in innovative technology that simplifies administration, connects healthcare networks, and streamlines payments, Accresa aims to help more employers, providers, and patients benefit from the affordability, accessibility, and personalized care that DPC makes possible.

About Accresa

Accresa is a healthcare technology company specializing in payment and administration solutions for direct primary care and other subscription-based healthcare models. Its patented technology supports healthcare affiliate management, network administration, and integrated payment infrastructure. Learn more at www.accresa.com.

Contacts

Anne Richter
arichter@aeperkins.co

Accresa


Release Summary
The only known patented DPC technology platform reinforces its intellectual property rights in healthcare affiliate management and payment technology.
Release Versions

Contacts

Anne Richter
arichter@aeperkins.co

More News From Accresa

Accresa Secures Groundbreaking Patent for Many-to-Many Healthcare Payments Software

CARROLLTON, Texas--(BUSINESS WIRE)--Accresa Secures Groundbreaking Patent for Many-to-Many Healthcare Payments Software...

Accresa Health and Beaufort Memorial Expand Access to Affordable Primary Care in the Lowcountry

BEAUFORT, S.C.--(BUSINESS WIRE)--Accresa Health and Beaufort Memorial have announced a new partnership in healthcare technology to make affordable primary care available to more people across the South Carolina Lowcountry. Accresa Health, a healthcare technology company specializing in payment and benefit administration solutions for employers and provider networks, is working with the growing South Carolina community health system, Beaufort Memorial, to expand the system’s Direct Primary Care...

Accresa and Intellect Partner to Offer Mental Wellbeing Support to America’s Workforce

DALLAS--(BUSINESS WIRE)--Accresa and Intellect Partner to Offer Mental Wellbeing Support to America’s Workforce....
Back to Newsroom